NXO
- Product code
- NXO
- Device name
- Calprotectin, Fecal
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5180
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 15 (all years; only the last 3 years are listed here)
FDA classification definition
The device is used for the measurement, in human stool, of fecal calprotectin, a neutrophilic protein that is a marker of mucosal inflammation. The device can be used as an aid in the diagnosis of inflammatory bowel disease (ibd), crohn's disease and ulcerative colitis and to differentiate ibd from irritable bowel syndrome.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K232057 | 2024-02-06 | Bühlmann Laboratories AG | BÜHLMANN fCAL® turbo and CALEX® Cap |
Official FDA classification page: NXO
Classification and pathway per current FDA publications. Data from openFDA (CC0).